US Federal House Bill HB5999

US Federal 2025-2026 Regular Session

• Introduced: 11/10/25
• Refer: 11/10/25
• Refer: 11/17/25
• Report Pass: 5/14/26

Caption

To amend title 38, United States Code, to direct the Secretary of Veterans Affairs to furnish an opioid antagonist to a veteran without requiring a prescription or copayment.

Impact

If passed, HB5999 would significantly alter the existing framework under which opioid antagonists are dispensed within the Veterans Affairs healthcare system. By removing the prescription requirement, the bill seeks to empower veterans by providing them easier and more immediate access to opioid antagonists, potentially reducing overdose deaths in this vulnerable population. The bill is designed to streamline the process through which veterans can obtain the medication necessary for combating opioid overdoses.

Summary

House Bill 5999 proposes an amendment to Title 38 of the United States Code, authorizing the Secretary of Veterans Affairs to provide opioid antagonists to veterans without requiring a prescription or copayment. The bill aims to facilitate immediate access to these potentially life-saving drugs, which can reverse the effects of opioid overdoses. Proponents of the bill argue that it addresses the urgent need for effective measures in the fight against the opioid crisis, particularly among veterans who may be at higher risk of opioid dependence due to pain management practices and other factors.

Contention

While advocates see this legislation as a step forward in public health for veterans, there could be contention surrounding the implications of such changes. Critics might express concerns regarding the ramifications of dispensing medications without prescriptions, including potential misuse or over-reliance on opioid antagonists. Furthermore, discussions may arise regarding the adequacy of accompanying support services for veterans, ensuring that distribution of these medications is paired with education on addiction and usage.